SilkChart analyses B2B sales calls against named methodologies – MEDDIC, Challenger Sales, SPIN, SPICED – tracking playbook adoption, comparing objection handling across reps, and generating an AI Coach’s feedback immediately after each call, with deal health indicators built from leading signals rather than a lagging pipeline stage. It integrates with calendars, Slack, email and CRM delivery. The company is based in San Francisco and backed by Y Combinator, SoftBank, GFC, Harlem Capital and Dentsu. A free plan includes unlimited call recordings.
Grading against a named, specific methodology rather than a generic AI-derived quality score is the difference that matters for sales coaching: a rep and a manager can both look at a MEDDIC scorecard and agree on what it means, where a vague ‘communication score’ invites argument about what the model actually measured. Immediate post-call feedback, rather than a weekly digest, is also the right cadence for coaching – the call is still fresh in the rep’s memory.
A YC and SoftBank-backed seed-stage company is a real, checkable pedigree, but still early-stage – worth confirming the specific methodology your team actually uses is supported well, since MEDDIC and Challenger scoring is not interchangeable. Full pricing is not shown beyond the free tier, so the cost of scaling past a small team is not visible upfront.
